Vericiguat reduced a composite of CV death or HF hospitalization in patients with HF and reduced LVEF.

Vericiguat reduced a composite of CV death or HF hospitalization in patients with HF and reduced LVEF. Ann Intern Med. 2020 Sep 15;173(6):JC30 Authors: Averbuch T, Van Spall HGC Abstract SOURCE CITATION: Armstrong PW, Pieske B, Anstrom KJ, et al. Vericiguat in patients with heart failure and reduced ejection fraction. N Engl J Med. 2020;382:1883-93. 32222134. PMID: 32926810 [PubMed - as supplied by publisher]
Source: Annals of Internal Medicine - Category: Internal Medicine Authors: Tags: Ann Intern Med Source Type: research